Yan Leyfman
Jun 20, 2025, 13:38
Yan Leyfman: FDA Approves Yeztugo, a Game-Changing HIV Prevention Drug
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Historic FDA Approval Alert!
The FDA has just approved Yeztugo (lenacapavir) – a game-changing HIV prevention drug that offers near-complete protection with just 1 injection every 6 months.
Hailed as the closest thing to an HIV vaccine, this breakthrough could finally help turn the tide on a 45-year pandemic. Unlike traditional PrEP, which requires daily pills, Yeztugo simplifies protection and brings us one step closer to ending HIV for good.”
More posts featuring Yan Leyfman.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 10, 2025, 09:06
Jul 10, 2025, 08:52
Jul 10, 2025, 08:35
Jul 10, 2025, 08:06
Jul 10, 2025, 06:53